Study: Weight Regain Starts 8 Weeks After Stopping Anti-Obesity Drugs

Swift Summary

• A study reviewed data from 11 clinical trials (1,573 participants) on weight-loss drugs including GLP-1 receptor agonists (e.g., semaglutide, liraglutide), orlistat, naltrexone-bupropion, and phentermine-topiramate.
• Weight regain started ~8 weeks after discontinuing the medications, progressed until around week 20, and stabilized by week 26.
• at the 52-week mark post-discontinuation, participants retained some weight loss compared to their pre-treatment baseline but less than during active treatment.
• Findings suggest those losing more weight during treatment were more prone to regaining it afterward.
• Individuals with a lower starting BMI experienced greater weight regain compared to higher BMI participants once medication stopped.
• Participants on GLP-1-related drugs showed higher rates of weight regain relative to other drug categories despite continued lifestyle interventions like diet and exercise.
• Experts note these findings align with past trials; discontinuation of medication or lifestyle modifications typically results in some degree of weight gain.
• Obesity experts emphasize the broader value of these expensive treatments as they offer non-surgical alternatives for sustained benefits beyond just immediate weight loss.

Indian Opinion Analysis
The study provides critical insights into the challenges posed by long-term obesity management using pharmaceuticals. While anti-obesity medications clearly show effectiveness in reducing body weight during active use, their discontinuation often leads to partial recurrences-a trend that highlights the necessity for prolonged treatment or complementary interventions like diet and exercise programs tailored specifically for individuals’ needs.

For India-where obesity is emerging as a major health concern alongside diabetes-the findings add urgency around addressing accessibility and affordability of such treatments in both urban centers and rural areas where obesity is rising steadily due to dietary transitions and sedentary lifestyles. The research also implies that public health strategies should strive not only for individual-level interventions but systemic lifestyle changes aimed at lasting long-term results.

Read more: [Link not provided]